United Therapeutics | UTHR - Market Capitalization


United Therapeutics reported $24.3B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 290M 51M Dec/2025
Ardelyx USD 1.48B 63M Mar/2026
Baxter International USD 11.01B 2.34B Jun/2026
Bayer EUR 47.7B 9.01B Aug/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.41B 550M Aug/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Gilead Sciences USD 162.48B 10.51B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Insmed USD 35.3B 1.82B Mar/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Pfizer USD 143.6B 5.16B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vertex Pharmaceuticals USD 121.59B 4.48B Aug/2026